Xencor Inc (XNCR) stock
XNCRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30194% above fair value
$34.39−0.11 (-0.32%)
Close on Nov 18, 2026Market cap $2.56BP/E –Yield –
Xencor cash
Cash and short-term investments held at the end of each period.
Xencor's cash was $44.66M at Jun 30, 2026. For fiscal 2025 it was $54.07M, up 31.0% from the year before. Over ten years it grew -5.6% a year on average. The highest annual figure on record is $529.78M in fiscal 2019.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $54.07M | +31.0% |
| FY2024 | Dec 31, 2024 | $41.26M | -23.8% |
| FY2023 | Dec 31, 2023 | $54.17M | +0.4% |
| FY2022 | Dec 31, 2022 | $53.94M | -62.4% |
| FY2021 | Dec 31, 2021 | $143.48M | -12.3% |
| FY2020 | Dec 31, 2020 | $163.54M | -69.1% |
| FY2019 | Dec 31, 2019 | $529.78M | +80.0% |
| FY2018 | Dec 31, 2018 | $294.36M | +31.3% |
| FY2017 | Dec 31, 2017 | $224.13M | +72.2% |
| FY2016 | Dec 31, 2016 | $130.14M | +35.0% |
| FY2015 | Dec 31, 2015 | $96.43M | +76.5% |
| FY2014 | Dec 31, 2014 | $54.65M | -29.9% |
| FY2013 | Dec 31, 2013 | $77.98M | +3272.6% |
| FY2012 | Dec 31, 2012 | $2.31M | -84.1% |
| FY2011 | Dec 31, 2011 | $14.54M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $44.66M | -0.1% |
| Q1 FY2026 | Mar 31, 2026 | $14.17M | -64.5% |
| Q4 FY2025 | Dec 31, 2025 | $54.07M | +31.0% |
| Q3 FY2025 | Sep 30, 2025 | $28.29M | -3.8% |
| Q2 FY2025 | Jun 30, 2025 | $44.73M | +43.6% |
| Q1 FY2025 | Mar 31, 2025 | $39.96M | +27.2% |
| Q4 FY2024 | Dec 31, 2024 | $41.26M | -23.8% |
| Q3 FY2024 | Sep 30, 2024 | $29.42M | -44.2% |
| Q2 FY2024 | Jun 30, 2024 | $31.15M | -10.3% |
| Q1 FY2024 | Mar 31, 2024 | $31.42M | -56.6% |
| Q4 FY2023 | Dec 31, 2023 | $54.17M | +0.4% |
| Q3 FY2023 | Sep 30, 2023 | $52.73M | +0.2% |
| Q2 FY2023 | Jun 30, 2023 | $34.71M | -29.8% |
| Q1 FY2023 | Mar 31, 2023 | $72.39M | -7.5% |
| Q4 FY2022 | Dec 31, 2022 | $53.94M | -62.4% |
| Q3 FY2022 | Sep 30, 2022 | $52.65M | +27.8% |
| Q2 FY2022 | Jun 30, 2022 | $49.41M | -57.3% |
| Q1 FY2022 | Mar 31, 2022 | $78.27M | -55.8% |
| Q4 FY2021 | Dec 31, 2021 | $143.48M | -12.3% |
| Q3 FY2021 | Sep 30, 2021 | $41.20M | -92.5% |
| Q2 FY2021 | Jun 30, 2021 | $115.84M | -80.2% |
| Q1 FY2021 | Mar 31, 2021 | $176.97M | -69.0% |
| Q4 FY2020 | Dec 31, 2020 | $163.54M | -69.1% |
| Q3 FY2020 | Sep 30, 2020 | $545.78M | -0.1% |
| Q2 FY2020 | Jun 30, 2020 | $583.65M | +15.5% |
| Q1 FY2020 | Mar 31, 2020 | $571.65M | +68.0% |
| Q4 FY2019 | Dec 31, 2019 | $529.78M | +80.0% |
| Q3 FY2019 | Sep 30, 2019 | $546.48M | +101.2% |
| Q2 FY2019 | Jun 30, 2019 | $505.17M | +97.8% |
| Q1 FY2019 | Mar 31, 2019 | $340.36M | -26.4% |
| Q4 FY2018 | Dec 31, 2018 | $294.36M | +31.3% |
| Q3 FY2018 | Sep 30, 2018 | $271.60M | +29.4% |
| Q2 FY2018 | Jun 30, 2018 | $255.41M | +35.5% |
| Q1 FY2018 | Mar 31, 2018 | $462.41M | +198.7% |
| Q4 FY2017 | Dec 31, 2017 | $224.13M | +72.2% |
| Q3 FY2017 | Sep 30, 2017 | $209.95M | +101.3% |
| Q2 FY2017 | Jun 30, 2017 | $188.49M | – |
| Q1 FY2017 | Mar 31, 2017 | $154.79M | – |
| Q4 FY2016 | Dec 31, 2016 | $130.14M | – |
| Q3 FY2016 | Sep 30, 2016 | $104.31M | – |
See a number that looks wrong?